Clinical Trials Logo

Breastcancer clinical trials

View clinical trials related to Breastcancer.

Filter by:

NCT ID: NCT03010371 Completed - Emotional Disorder Clinical Trials

Presential Vs Online Group-based Psychosocial Treatment for Breast Cancer Survivors.

PSONLINE
Start date: January 2016
Phase: N/A
Study type: Interventional

This multicenter study is a sequential RCT which aims to prove, in the first stage, the efficacy of a face-to-face Positive Psychotherapy in Cancer (PPC) group compared to a Cognitive Behavioral Stress Management (CBSM) group. In the second stage, the common face-to-face version of the PPC will be compared with its online version via videoconference (Online group Positive Psychotherapy, OPPC) among a group of primary breast cancer survivors. The principal dependent variables assessed will be emotional distress, post-traumatic growth (PTG) and quality of life (QoL). Some treatment predictors of psychosocial response will be explored. Lastly, an economic analysis focused on the Quality Adjusted Life Years (QALY) will be carried out at each stage. For the first stage, we hypothesize that the PCC group would achieve similar efficacy in reducing participants' distress compared to the CBSM group, while the PCC group would show greater improvement in PTG than the CBSM group. For the second stage, it is hypothesized that the OPCC would achieve similar efficacy in all psychosocial variables and guarantee equivalent retention and adherence compared to face-to-face PPC.

NCT ID: NCT02997384 Active, not recruiting - Breastcancer Clinical Trials

Feasibility of Breast Cancer Risk Evaluation in Women From the General Population

RIVIERA
Start date: December 2016
Phase: N/A
Study type: Observational

This study aims to evaluate the feasibility (acceptability) of a consultation dedicated to informing women about their risk of breast cancer and the screening methods recommended for them according to the recommendations in force during a routine consultation at a general practitioner, a gynecologist or a radiologist.

NCT ID: NCT02996240 Completed - Breastcancer Clinical Trials

Breast, Omega 3 Free Fatty Acid, Ph 0

Start date: June 12, 2017
Phase: N/A
Study type: Interventional

Assess the impact of dietary omega 3 free fatty acids breast cancer patients.

NCT ID: NCT02992574 Recruiting - Breastcancer Clinical Trials

Trial Evaluating Role of Post Mastectomy Radiotherapy in Women With Node Negative Early Breast Cancer

PMRT-NNBC
Start date: May 27, 2016
Phase: N/A
Study type: Interventional

Postmastectomy radiotherapy (PMRT) is unequivocally beneficial in reducing the recurrences as well as improving survival in node positive breast cancer patients. PMRT for women with T1-T2 tumors and negative axillary nodes is not generally warranted because of the presumed low risk of recurrence in this population as a whole. However, in the setting of multiple adverse prognostic factors, the recurrence risk approaches and in some cases surpasses the risk of recurrence documented for patients with one to three positive lymph nodes. Numerous retrospective series have reported the outcome and patterns of failure for post-mastectomy patients treated without radiation. Many of these series have analyzed several high risk factors which were predictive of loco-regional recurrence wherein the role of adjuvant post-mastectomy radiation can be considered. Some authors have used combinations of prognostic factors, such as age, tumour size, grade, receptor status, Her2neu status and lympho-vascular space invasion to define subgroups with more specific risks of loco-regional recurrence than single factors alone. The current trial hypothesizes that "Post-mastectomy radiation in high risk, node negative early breast cancer patients decreases rates of loco-regional recurrence and improves disease free survival" and propose to address the question in randomized setting.

NCT ID: NCT02992067 Completed - Breastcancer Clinical Trials

CK19 Combined With Contrast-enhanced Ultrasound: a Prediction System on Axillary Lymph Node Metastasis in Breast Cancer

CK-CEUS
Start date: April 2015
Phase:
Study type: Observational

To establish a predicting system on axillary lymph node metastasis based on peripheral blood CK19mRNA and contrast-enhanced ultrasound.

NCT ID: NCT02975128 Terminated - Breastcancer Clinical Trials

Minimal Invasive Breast Cancer Excision Using the Breast Lesion Excision System Under Ultrasound Guidance

BLES
Start date: February 19, 2018
Phase: N/A
Study type: Interventional

This study will assess whether it is feasible to remove small breast cancers completely using the Breast Lesion Excision System under Ultrasound guidance.

NCT ID: NCT02967146 Recruiting - Breastcancer Clinical Trials

Anti-adhesive Effect and Safety of a Mixed Solid of Poloxamer, Gelatin and Chitosan(Mediclore®) After Axillary Dissection for Breast Cancer

Start date: November 2016
Phase: Phase 3
Study type: Interventional

Anti-adhesive effect and Safety of a mixed solid of poloxamer, gelatin and chitosan(Mediclore®) after axillary dissection for breast cancer

NCT ID: NCT02964234 Completed - Breast Diseases Clinical Trials

Empowering Latinas to Obtain Breast Cancer Screenings

Start date: March 1, 2017
Phase: N/A
Study type: Interventional

The participatory-based project will quantify the 'added benefit' of an empowerment intervention relative to an education intervention for 150 Latinas on the following outcomes: women's adherence to breast cancer screening guidelines; women's psychosocial facilitators (self-efficacy, norms, support, and knowledge); and women's dissemination of breast health messages throughout their social network. The empowerment intervention will train Latinas in how to discuss breast health with their family and friends and volunteer in local breast health promotion programs. Academic, clinician, and community partners will work together throughout intervention development and evaluation.

NCT ID: NCT02958332 Completed - Lymphedema Clinical Trials

Effects of a Videogame-based Program on Women With Lymphedema Secondary to Breast Cancer

Start date: November 2016
Phase: N/A
Study type: Interventional

Aims: To demonstrate the effect of a program based on video games as a means to improve abilities and basic skills affected by lymphedema, and its impact on quality of life. Design: longitudinal, pre-experimental, with pre / post-test and evaluation, assessor blinded study. Method: Data on shoulder pain and disability, health-related quality of life, strength and articulate activated by the OSS (Oxford Shoulder Score), SPADI (Shoulder Pain and Disability Index), FACT-B + 4 (Functional Assesment of Cancer Therapy Questionnaire for Breast Cancer), respectively goniometry and dynamometry amplitude scales will be collected. The intervention will be performed with the Wii ™ console and the Wii Balance BoardTM, during 5 individual weekly sessions of 30 minutes.

NCT ID: NCT02944604 Completed - Breastcancer Clinical Trials

The Efficacy and Safety of PEG-rhG-CSF(Pegylated Recombinant Human Granulocyte Colony Stimulating Factor)in Patients With Breast Cancer Who Were Treated With Intensive Chemotherapy

Start date: September 8, 2016
Phase: Phase 4
Study type: Interventional

The purpose of the study is to evaluate the efficacy and safety of PEG-rhG-CSF in patients with breast cancer who were treated with intensive chemotherapy for prevention of neutrophil reduction.